Platinumcare , LLC

Platinumcare , LLC was paid $1.01M by Medicaid between Jan 2018 and May 2024, across 32 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 48% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	5,460	$125K
2019	6,445	$197K
2020	2,486	$19K
2021	3,491	$130K
2022	3,895	$172K
2023	5,167	$254K
2024incomplete	2,020	$113K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	48%	6,166	5,085	$488K
99401		19%	7,695	6,314	$188K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	17%	3,454	3,028	$171K
99354		4.2%	808	689	$43K
99406		3.4%	3,444	2,881	$34K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	3.3%	889	763	$33K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	1.1%	125	117	$11K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.1%	566	463	$11K
93000		<1%	514	486	$6K
99496		<1%	28	24	$5K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	<1%	31	30	$4K
99408		<1%	132	92	$2K

20 more codes

36415	Collection of venous blood by venipuncture	<1%	1,063	$2K
87481		<1%	41	$2K
82948		<1%	707	$2K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	38	$1K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	50	$1K
99203	Doctor's office visit, new patient (routine)	<1%	15	$1K
81000		<1%	522	$1K
93922		<1%	26	$1K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	24	$831.84
94060		<1%	12	$628.65
81003		<1%	377	$519.69
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	18	$225.44
90749		<1%	13	$109.33
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	16	$79.32
97802		<1%	66	$61.30
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	33	$10.67
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	17	$3.69
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	0%	588	$0.00
G0442	Annual alcohol misuse screening, 5 to 15 minutes	0%	64	$0.00
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	0%	1,422	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCLAUGHLIN EDWARDS, JACQUE (CEO)